Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) EPS (Weighted Average and Diluted): 2010-2025

Historic EPS (Weighted Average and Diluted) for OptimizeRx (OPRX) over the last 15 years, with Q3 2025 value amounting to $0.04.

  • OptimizeRx's EPS (Weighted Average and Diluted) rose 10800.0% to $0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.04, marking a year-over-year increase of 10800.0%. This contributed to the annual value of -$1.1 for FY2024, which is 679.61% down from last year.
  • Latest data reveals that OptimizeRx reported EPS (Weighted Average and Diluted) of $0.04 as of Q3 2025, which was up 10800.0% from $0.08 recorded in Q2 2025.
  • OptimizeRx's 5-year EPS (Weighted Average and Diluted) high stood at $0.26 for Q4 2024, and its period low was -$0.5 during Q3 2024.
  • For the 5-year period, OptimizeRx's EPS (Weighted Average and Diluted) averaged around -$0.13, with its median value being -$0.17 (2023).
  • Per our database at Business Quant, OptimizeRx's EPS (Weighted Average and Diluted) crashed by 876721.38% in 2022 and then surged by 20746.41% in 2024.
  • OptimizeRx's EPS (Weighted Average and Diluted) (Quarter) stood at $0.03 in 2021, then plummeted by 166.67% to -$0.02 in 2022, then tumbled by 1100.0% to -$0.24 in 2023, then skyrocketed by 207.46% to $0.26 in 2024, then crashed by 84.49% to $0.04 in 2025.
  • Its last three reported values are $0.04 in Q3 2025, $0.08 for Q2 2025, and -$0.12 during Q1 2025.